Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists

Neprilysin inhibitors

Insecticidal compositions and methods

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

HETEROCYCLIC COMPOUND

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

Tricyclic spiro compound

Pyrone based compounds for treating bacterial infections

Kinase inhibitors

Aryl-or heteroaryl-substituted benzene compounds

Pyrazolone derivatives as nitroxyl donors

Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient

Pro-Neurogenic Compounds

Lipid derivative in which hydrophilic polymer is bound through cyclic benzylidene acetal linker

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

Benzopiperazine compositions as BET bromodomain inhibitors

Fused indazole pyridone compounds as antivirals

Nitrogen-containing aromatic heterocyclic compound

Polymorphic forms of Afatinib free base and Afatinib dimaleate

Substituted indazole compounds as RORgammaT inhibitors and uses thereof

Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors

Derivatives of halo quinabactin

DNA-PK INHIBITORS

PYRIMIDINEDIONE COMPOUNDS

Opioid receptor ligands and methods of using and making same

PPAR agonists and methods of use thereof

Kinase inhibitors

COMPOSITIONS AND METHODS FOR ENHANCING ONCOLYTIC VIRUS EFFICACY

Compounds for treating mitochondrial disease

Disubstituted 1, 2, 4-triazine compound

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

Alkynyl pyridine prolyl hydroxylase inhibitor, and preparation method and medical use thereof

COLORED PHOTOSENSITIVE RESIN COMPOSITION AND LIGHT SHIELDING SPACER PREPARED THEREFROM

EBNA1 inhibitors and methods using same

N-hydroxylsulfonamide derivatives as nitroxyl donors

PRMT5 inhibitors and uses therof

Alkyne Compounds for Treatment of Complement Mediated Disorders

Piperidine derivative and preparation method and pharmaceutical use thereof

PRMT5 INHIBITORS AND USES THEREOF

Process for the preparation of N-[4-[(3-chloro-4-fluoro phenyl) amino]-7-[[(3s-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethyl amino)-(2E)-2-butenamide (2Z)-2-butenedioate (1:2) and its polymorphs thereof

Benzimidazole derivatives, preparation method therefor, and applications thereof

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

MYC MODULATORS AND USES THEREOF

Processes for making triazolo[4,5D] pyramidine derivatives and intermediates thereof

BRD4-kinase inhibitors as cancer therapeutics

ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

Monocarboxylate transport modulators and uses thereof

Urea derivative or pharmacologically acceptable salt thereof

Compounds useful as modulators of TRPM8

CRMP2 SUMOylation inhibitors and uses thereof

Covalent small molecule DCN1 inhibitors and therapeutic methods using the same

Substituted indazole derivatives active as kinase inhibitiors

Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors

Compound and organic light emitting diode comprising same

CARM1 inhibitors and uses thereof

3-(CARBOXYMETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES

Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors

1,3-benzodioxole derivative

Hydrochloride salt form for EZH2 inhibition

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

Pyridinone dicarboxamide for use as bromodomain inhibitors

Azolylacryloyl derivatives as therapeutic agents for sickle cell disease

Compound for organic electric element, organic electric element comprising the same and electronic device thereof

Pyridone compounds and agricultural and horticultural fungicides containing said compounds as active ingredient

Compound and organic electronic device comprising same

Bromodomain inhibitors

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

3-(CARBOXYETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES

AMINE DERIVATIVES AS POTASSIUM CHANNEL BLOCKERS

Hydrophilic fentanyl derivatives

Materials for organic electroluminescent devices

SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS

Apelin receptor (APJ) agonists and uses thereof

Cyclopropanecarboxamide modulators of cystic fibrosis transmembrane conductance regulator

Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t))

Anticancer agent

Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer

PSMA imaging agents

Labeled chemically reactive and biologically active conjugates, and methods and compositions thereof

Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

Human plasma kallikrein inhibitors

Oxy-cyanoquinolinone PDE9 inhibitors

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS

Pyrimidinone amide compounds as PDE2 inhibitors

Methods and compositions of inhibiting DCN1-UBC12 interaction

Compound for organic electronic element, organic electronic element using same, and electronic device comprising same

Histone demethylase inhibitors

DNA binding agents with a minor groove binding tail

METHOD OF TREATING OR PREVENTING RAS-MEDIATED DISEASES

Ion-activated photolabile compounds

Amino pyrimidine derivatives

Farnesoid X receptor agonists and uses thereof

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereof

POSITIVE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTOR

Materials for electronic devices

ANTIVIRAL COMPOUNDS

Dual mechanism inhibitors for the treatment of disease

HIGHLY SENSITIVE DETECTION OF BIOMOLECULES USING PROXIMITY INDUCED BIOORTHOGONAL REACTIONS

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

HIV replication inhibiting pyrimidines

INHIBITION OF OLIG2 ACTIVITY

Heterocyclic compounds and uses thereof

Salt form of a human histone methyltransferase EZH2 inhibitor

INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF

SYNERGISTIC FUNGICIDAL MIXTURES FOR FUNGAL CONTROL IN CEREALS

MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

Fluorogenic pH sensitive dyes and their method of use

Inhibitors of β-hydroxylase for treatment of cancer

Neprilysin inhibitors

Urea derivative and use therefor

PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

Crystal form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxole-5-yl)cyclopropane formamido)-3-methylpyridine-2-yl)benzoic acid and preparation method thereof

Triazole compounds as T-type calcium channel blockers

Heterocyclic compounds for the inhibition of PASK

Picolinamide compounds with fungicidal activity

Amine-based compound and organic light-emitting device including the same

N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof

Heterocyclic compounds useful as modulators of TNF alpha

3-indol substituted derivatives, pharmaceutical compositions and methods for use

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

Compounds and their use as BACE inhibitors

MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES

PLANT GROWTH REGULATOR COMPOUNDS

COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE

Compounds and methods for inhibiting fascin

Dual mechanism inhibitors for the treatment of disease

1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

2-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane derivatives as alpha2C antagonists

Inhibitors of ACK1/TNK2 tyrosine kinase

LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF

Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders

Substituted quinolinones as PDE9 inhibitors

Substituted furano-/thienocycloalkylamino-2-pyrimidine derivatives and use thereof for controlling undesired plant growth

Substituted oxazoles for the treatment of cancer

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

Pyrimidine derivatives for the treatment of viral infections

Aryloxypyrimidinyl ethers as herbicides

SUBSTITUTED CYCLIC ARYL AND HETEROARYL CARBOXYLIC ACID HYDRAZIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS

Heterocycle derivatives having TrkA inhibitory activity

P2X4 receptor antagonist

Agent for treating and/or preventing adult T cell leukemia/lymphoma

Triazolone compounds as MPGES-1 inhibitors

Bridged bicyclic kallikrein inhibitors

Neprilysin inhibitors

Bicyclic heterocyclic amide derivative

HETERO-HALO INHIBITORS OF HISTONE DEACETYLASE

Substrate selective inhibitors of insulin-degrading enzyme (IDE) and uses thereof

NEPRILYSIN INHIBITORS

Polymorphs and process for the preparation of quinazolinyl derivatives

Compounds for the treatment of HIV

Methods to treat lymphoplasmacytic lymphoma

Hydantoin containing deoxyuridine triphosphatase inhibitors

THERAPEUTIC COMPOUNDS

NEPRILYSIN INHIBITORS

Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device

ANTIVIRAL COMPOUNDS

PRMT5 INHIBITORS AND USES THEREOF

Inhibitors of protein kinases

G protein-coupled receptor kinase inhibitors and methods for use of the same

Sulfonamide compounds as voltage-gated sodium channel modulators

Hesperetin aza-cinnamic acid derivatives with anti-tumor activities and a method of preparing the same

LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF

6-aminoisoquinoline compounds

Histone methyltransferase inhibitors

Compounds for inhibiting c-myc/max/DNA complex formation

Spiro[cyclobutane-1,3′-indolin]-2′-one derivatives as bromodomain inhibitors

Hydantoin containing deoxyuridine triphosphatase inhibitors

Phthalazinone derivatives

Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic device

Compound for organic electric element, organic electric element comprising the same and electronic device thereof

N-sulfonyl homoserine lactone derivatives, preparation method and use thereof

SMALL MOLECULE INHIBITORS OF GP120-MEDIATED HIV INFECTION AND METHODS OF USE

C5aR antagonists

1,4-substituted piperidine derivatives

Efflux-pump inhibitors and therapeutic uses thereof

Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

Piperidine derivative and preparation method and pharmaceutical use thereof

Pyrimidine-2,4-diamine derivatives for treatment of cancer

Substituted pyrazines as ATR kinase inhibitors

Compounds and compositions as RAF kinase inhibitors

Inhibitors of CXCR2

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

Substituted β-lapachones for treating cancer

Hsp70 modulators and methods for making and using the same

PPAR agonists

HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO

PLANT GROWTH REGULATING COMPOUNDS

Compounds useful in the synthesis of halichondrin B analogs

PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF

CYCLOPROPANE DERIVATIVE AND DRUG CONTAINING SAME

Modulators of ATP-binding cassette transporters

Phthalazinones and isoquinolinones as rock inhibitors

DNA-PK inhibitors

SHIP1 modulators and methods related thereto

Inhibitors of LecB

Inhibitors of ACK1/TNK2 tyrosine kinase

CXCR4 chemokine receptor modulators

Mixed disulfide conjugates of thienopyridine compounds and uses thereof

Aza spiro alkane derivatives as inhibitors of metalloproteases

Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof

N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

Benzoimidazol-1,2-yl amides as Kv7 channel activators

AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES

Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

Direct inhibitors of Keap1-Nrf2 interaction as antioxidant inflammation modulators

Modulators of chemokine receptors

Substituted piperazines as selective HDAC1,2 inhibitors

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

ROR gamma (RORγ) modulators

INDOLE AND AZAINDOLE DERIVATIVE HAVING AMPK-ACTIVATING ACTIVITY

Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

Cannabinoid receptor CB2 ligand 4-(aminomethyl)-N,N-dialkylanilines

Inhibitors of RAD52 recombination protein and methods using same

Oxindole compounds and pharmaceutical compositions thereof

Salts and prodrugs of 1-methyl-D-tryptophan

Therapeutic compounds and uses thereof

Bicyclic-fused heteroaryl or aryl compounds

Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof

Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

5-substituted indazole-3-carboxamides and preparation and use thereof

Tricyclic sulfones as ROR gamma modulators

Pro-Neurogenic Compounds

Lipids and compositions for the delivery of therapeutics

Substituted quinazolines for inhibiting kinase activity

PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS

AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME

Compounds for improving mRNA splicing

Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof

P-toluenesulfonate for MEK kinase inhibitor, and crystal form thereof and preparation method therefor

Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compound

Compounds for treating parasitic infections

6-membered heterocyclic derivatives and pharmaceutical composition comprising the same

Heterocyclic derivatives modulating activity of certain protein kinases

Indolone compounds and their use as AMPA receptor modulators

Compositions and methods for viral sensitization

Deuterated CFTR modulators

Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer

Amino-substituted heterocyclic derivatives as sodium channel inhibitors

ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

Pyrazole compounds and their use as T-type calcium channel blockers

Phenanthrene compounds for organic electronic devices

Inhibitors of histone deacetylase

Compounds as rearranged during transfection (RET) inhibitors

Benzofurans substituted with secondary benzamide as HCV inhibitors

PRMT5 Inhibitors and Uses Thereof

Anesthetic compounds and related methods of use

Organic compound, and organic light emitting diode and organic light emitting display device including the same

Use of physiological cooling active ingredients, and agents containing such active ingredients

2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors

Pyridazinone compounds and methods for the treatment of cystic fibrosis

Quinoline derivatives as inhibitors of heat shock factor 1 pathway activity

Lipids and compositions for the delivery of therapeutics

Quinazolinones as bromodomain inhibitors

Somatostatin receptor subtype 4 (SSTR4) agonists

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

Substituted indazoles for treating tendon and/or ligament injuries

CGAS in systemic lupus erythematosus (SLE)

Disubstituted piperidines as butyrylcholinesterase inhibitors

Nitrobenzyl derivatives of anti-cancer agents

Amino-quinolines as kinase inhibitors

Methods for treating cancer with RORγ inhibitors

Heterocyclic modulators of lipid synthesis

9-membered fused ring derivative

Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

Condensed-cyclic compound and organic light-emitting device comprising the same

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

4,5-substituted picolinamide and picolinonitrile metabotropic glutamate receptor 2 negative allosteric modulators

Selective FKBP51 ligands for treatment of psychiatric disorders

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

Carbazole-containing sulfonamides as cryptochrome modulators

SUBSTITUTED CYCLIC ETHER POLYMERS AND CONJUGATES AND USES THEREOF

SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors

ANTIVIRAL COMPOUNDS

Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

AMPK-activating heterocyclic compounds and methods for using the same

Compounds useful as immunomodulators

USE OF PRO-FUNGICIDES OF UK-2A FOR CONTROL OF BROWN ROT DIESEASE ON STONE AND POME FRUITS

Amide compounds as 5-HT4 receptor agonists

Compounds and compositions for inhibition of FASN

Neprilysin inhibitors

Substituted cyclic amides as herbicides

Histone demethylase inhibitors

Piperazine derivatives for treating disorders

Phthalazinone compounds and methods for the treatment of cystic fibrosis

Peptidyl nitril compounds as dipeptidyl peptidase I inhibitors

Method of treating or preventing Ras-mediated diseases